scholarly journals 787: LATE-ONSET MAPLE SYRUP URINE DISEASE TRIGGERED BY HHV-6-MEDIATED TOXIC-METABOLIC ENCEPHALOPATHY

2021 ◽  
Vol 50 (1) ◽  
pp. 388-388
Author(s):  
Jack Green
Author(s):  
Jianmei Yang ◽  
Jianjun Xiu ◽  
Yan Sun ◽  
Fan Liu ◽  
Xiaohong Shang ◽  
...  

Abstract Background Maple syrup urine disease (MSUD) is a rare metabolic autosomal recessive disorder caused by deficiency of the branched-chain α-ketoacid dehydrogenase complex. Mutations in the BCKDHA, BCKDHB and DBT genes are responsible for MSUD. This study presents the clinical and molecular characterizations of four MSUD patients. Methods Clinical data of patients were retrospectively analyzed, and genetic mutations were identified by whole-exome sequencing. CLUSTALX was employed to analyzed cross-species conservation of the mutant amino acid. The impact of the mutations was analyzed with PolyPhen-2 software. The I-TASSER website and PyMOL software were used to predict the protein three-position structure of the novel mutations carried by the patients. Results Vomiting, irritability, feeding difficulties, seizures, dyspnoea, lethargy and coma were the main clinical presentations of MSUD. Cranial MRI showed abnormal symmetrical signals in accordance with the presentation of inherited metabolic encephalopathy. Seven mutations were detected in four patients, including three novel pathogenic mutations in the BCKDHA (c.656C>A), BCKDHB (deletion of a single-copy of BCKDHB) and DBT (c.1219dup) genes. Structural changes were compatible with the observed phenotypes. Conclusions Different types of MSUD can display heterogeneous clinical manifestations. Exhaustive molecular studies are necessary for a proper differential diagnosis. The newly identified mutation will play a key role in the prenatal diagnosis of MSUD in the future.


2013 ◽  
Vol 33 (3) ◽  
pp. 230-233
Author(s):  
Diva Shah ◽  
Apoorv Nirula ◽  
Dwiti Shah

The newborn presenting with neurological symptoms such as seizures or lethargy due to inborn error of metabolism is an important problem. Maple syrup urine disease (MSUD) is an inherited genetic disease, caused by a deficiency of the catalytic components of α-ketoaciddehydrogenase complex, which is responsible for the catabolism of branched-chain amino acids. The purpose of this case report is to show diffusion-weighted imaging (DWI) MRI findings of acute phase of classic form of MSUD in a newborn although this imaging findings are rare but very typical, known as “MSUD oedema”. DOI: http://dx.doi.org/10.3126/jnps.v33i3.8365   J. Nepal Paediatr. Soc. 2013;33(3):230-233


PEDIATRICS ◽  
1961 ◽  
Vol 28 (6) ◽  
pp. 918-923
Author(s):  
Manford D. Morris ◽  
Bernard D. Lewis ◽  
Paul D. Doolan ◽  
Harold A. Harper

A previously healthy female child first developed episodes of ataxia, lethargy and semicoma following otitis media at the age of 16 months. Subsequently she had a convulsion, and ventriculograms were taken. The attacks, lasting 1 to 4 days, recurred several times over a 12-month period. During these attacks, it was noted that the urine of the patient had an odor resembling that of maple syrup. Biochemical studies revealed that at intermittent intervals she excreted abnormally large amounts of keto acids. However, when the patient was asymptomatic, the urinary pattern of keto acids was indistinguishable from that of the control subjects. The late onset and the episodic nature of the disease, as well as the fact that the physical and mental development of the child have progressed normally to the present age of 41 months, indicate that this case may represent the first reported variant of the previously reported cases of maple syrup urine disease.


2020 ◽  
Vol 7 (10) ◽  
pp. 2072
Author(s):  
Rohini Patil ◽  
Giridhar S. ◽  
Umadevi L. ◽  
Rathinasamy M. ◽  
Antony J

We report a 17 day old boy, who developed progressive encephalopathy, after an apparent period of normalcy. Magnetic resonance imaging showed diffusion restriction in myelinated areas like, a pattern suggestive of maple syrup urine disease. Dried blood spots for tandem mass spectrometry and urine for gas chromatography mass spectrometry confirmed elevation and excretion of branched chain amino acids respectively.  After peritoneal dialysis, baby improved but continued to have residual neurological deficit, in spite of MSUD-specialized diet. Molecular studies confirmed the diagnosis. This report highlights the need for early identification of these infants to optimize neurological outcomes.


2006 ◽  
Vol 37 (03) ◽  
Author(s):  
V Boda ◽  
S Vlaho ◽  
S Dittrich ◽  
M Baz Bartels ◽  
S Parbel ◽  
...  

2021 ◽  
Vol 27 ◽  
pp. 100745
Author(s):  
Michelle E. Abadingo ◽  
Mary Ann R. Abacan ◽  
Jeanne Ruth U. Basas ◽  
Carmencita D. Padilla

2021 ◽  
Vol 7 (2) ◽  
pp. 25
Author(s):  
Mona Sajeev ◽  
Sharon Chin ◽  
Gladys Ho ◽  
Bruce Bennetts ◽  
Bindu Parayil Sankaran ◽  
...  

Maple syrup urine disease is caused by a deficiency of branched-chain alpha-ketoacid dehydrogenase, responsible for degradation of leucine, isoleucine, and valine. Biallelic pathogenic variants in BCKDHA, BCKDHB, or DBT genes result in enzyme deficiency. We report the case of a female infant who presented with mild gross motor delay at 4 months, and seizures with hypoglycaemia at 5 months. Newborn screening returned total leucine/isoleucine at the 99.5th centile of the population; however, as second-tier testing reported minimal alloisoleucine, the results were considered inconsistent with MSUD. Plasma amino acid and urine organic acid analyses at 5 months were, however, consistent with a diagnosis of MSUD. A brain MRI showed bilateral symmetrical T2 hyperintense signal abnormalities involving white matter, globus pallidus, thalamus, brainstem, and dentate nuclei with restricted diffusion. A repeat MRI 10 months post-dietary-intervention showed the resolution of these changes and progression in myelination. Her clinical phenotype, including protein tolerance, correlated with intermediate MSUD. Molecular analysis of all three genes identified two variants of uncertain significance, c.434-15_434-4del and c.365A>G (p. Tyr122Cys) in the DBT gene. The rate of leucine decarboxylation in fibroblasts was reduced, but not to the extent observed in classical MSUD patients, supporting an intermediate form of MSUD. Previously reported mRNA splicing studies supported a deleterious effect of the c.434-15_434-4del variant. This functional evidence and confirmation that the variants were in trans, permitted their reclassification as pathogenic and likely pathogenic, respectively, facilitating subsequent prenatal testing. This report highlights the challenges in identifying intermediate MSUD by newborn screening, reinforcing the importance of functional studies to confirm variant pathogenicity in this era of molecular diagnostics.


Author(s):  
Diana Ruffato Resende Campanholi ◽  
Ana Vitoria Barban Margutti ◽  
Wilson A. Silva ◽  
Daniel F. Garcia ◽  
Greice A. Molfetta ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document